These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27187159)

  • 1. Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group
    Nappi RE; Biglia N; Cagnacci A; Di Carlo C; Luisi S; Paoletti AM
    Gynecol Endocrinol; 2016 Aug; 32(8):602-606. PubMed ID: 27187159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.
    Nappi RE; Palacios S; Panay N; Particco M; Krychman ML
    Climacteric; 2016 Apr; 19(2):188-97. PubMed ID: 26581580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide.
    Hirschberg AL; Bitzer J; Cano A; Ceausu I; Chedraui P; Durmusoglu F; Erkkola R; Goulis DG; Kiesel L; Lopes P; Pines A; van Trotsenburg M; Lambrinoudaki I; Rees M
    Maturitas; 2021 Jun; 148():55-61. PubMed ID: 33896654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estradiol softgel inserts for the treatment of VVA symptoms: an expert opinion.
    Liu JH; Bernick B; Mirkin S
    Expert Opin Drug Deliv; 2020 Nov; 17(11):1573-1581. PubMed ID: 32877254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey.
    Kingsberg SA; Wysocki S; Magnus L; Krychman ML
    J Sex Med; 2013 Jul; 10(7):1790-9. PubMed ID: 23679050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of vulvovaginal atrophy on women's quality of life from an Italian cohort of the EVES study.
    Nappi RE; Di Carlo C; Becorpi AM; Gambacciani M; De Seta F; Ribaldone R; Benedetto C; Paoletti AM;
    J Obstet Gynaecol; 2020 May; 40(4):512-519. PubMed ID: 31496326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic effect of dehydroepiandrosterone (DHEA) on vulvovaginal atrophy.
    Wang J; Wang L
    Pharmacol Res; 2021 Apr; 166():105509. PubMed ID: 33610719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of vulvovaginal atrophy of menopause: prevalence and symptoms in Italian women according to the EVES study.
    Nappi RE; Seracchioli R; Salvatore S; Cagnacci A; Di Paolantonio T; Busacca M;
    Gynecol Endocrinol; 2019 May; 35(5):453-459. PubMed ID: 30700188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The European Vulvovaginal Epidemiological Survey (EVES): impact on sexual function of vulvovaginal atrophy of menopause.
    Particco M; Djumaeva S; Nappi RE; Panay N; Palacios S;
    Menopause; 2020 Apr; 27(4):423-429. PubMed ID: 32068686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause.
    Palacios S; Nappi RE; Bruyniks N; Particco M; Panay N;
    Climacteric; 2018 Jun; 21(3):286-291. PubMed ID: 29553288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vulvovaginal atrophy of menopause and its impact on sexual function in an Italian clinical cohort of post-menopausal women.
    Nappi RE; Guida M; Marchesoni D; Cianci A; Pellegrino A; Remorgida V; Di Paolantonio T; Benedetti Panici P;
    J Obstet Gynaecol; 2021 Feb; 41(2):290-297. PubMed ID: 33432869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of genitourinary conditions in women with a diagnosis of vulvar/vaginal atrophy.
    Constantine GD; Bruyniks N; Princic N; Huse D; Palmer L; Lenhart G; Blumentals WA; Nappi RE
    Curr Med Res Opin; 2014 Jan; 30(1):143-8. PubMed ID: 24083677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease.
    Pérez-López FR; Phillips N; Vieira-Baptista P; Cohen-Sacher B; Fialho SCAV; Stockdale CK
    Gynecol Endocrinol; 2021 Aug; 37(8):746-752. PubMed ID: 34169794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association Between Vulvovaginal Atrophy Symptoms and Quality of Life Among Postmenopausal Women in the United States and Western Europe.
    DiBonaventura M; Luo X; Moffatt M; Bushmakin AG; Kumar M; Bobula J
    J Womens Health (Larchmt); 2015 Sep; 24(9):713-22. PubMed ID: 26199981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WISDOM survey: attitudes and behaviors of physicians toward vulvar and vaginal atrophy (VVA) treatment in women including those with breast cancer history.
    Kingsberg SA; Larkin L; Krychman M; Parish SJ; Bernick B; Mirkin S
    Menopause; 2019 Feb; 26(2):124-131. PubMed ID: 30130293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vulvovaginal atrophy.
    Mac Bride MB; Rhodes DJ; Shuster LT
    Mayo Clin Proc; 2010 Jan; 85(1):87-94. PubMed ID: 20042564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy.
    Pinkerton JV; Stanczyk FZ
    Menopause; 2014 Mar; 21(3):309-19. PubMed ID: 23777900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning.
    Pinkerton JV; Bushmakin AG; Komm BS; Abraham L
    Maturitas; 2017 Jun; 100():57-63. PubMed ID: 28539177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iranian postmenopausal women's experiences of treatment of symptomatic vulvovaginal atrophy.
    Fooladi E; Deldar M; Mohammadzadeh F; Ahmadnia E; Khani S; Ghanbari Z
    Climacteric; 2017 Feb; 20(1):67-71. PubMed ID: 28064523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy.
    Pérez-López FR; Vieira-Baptista P; Phillips N; Cohen-Sacher B; Fialho SCAV; Stockdale CK
    Gynecol Endocrinol; 2021 Aug; 37(8):740-745. PubMed ID: 34036849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.